emtricitabine – Page 2 – SASHA: South Australian Sexual Health Awareness

Expanded HIV PrEP implementation in communities in NSW (EPIC-NSW): design of an open label, single arm implementation trial

2 Min Read

E

BMC Public Health Published: 2 February 2018 Abstract: Background The New South Wales (NSW) HIV Strategy 2016–2020 aims for the virtual elimination of HIV transmission in NSW, Australia, by 2020. Despite high and increasing levels of HIV testing and treatment since 2012, the annual number of HIV diagnoses in NSW has remained generally unchanged. Pre-exposure prophylaxis (PrEP) is highly...

Read on Read later

The updated 2017 ASHM HIV pre-exposure prophylaxis (PrEP) Guidelines

By J Pope

In HIV, Safer sex

2 Min Read

T

Journal of Virus Eradication, 2017; 3: 168–184 Daily use of co-formulated tenofovir and emtricitabine for HIV pre-exposure prophylaxis (PrEP) by populations at high risk of HIV infection is now recommended in guidelines from the United States, Europe and Australia and globally through the 2015 WHO guidelines. These 2017 Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine‘s...

Read on Read later

UK report gives thumbs up to generic HIV drugs used as PrEP

By J Pope

In HIV

1 Min Read

U

A sexual health clinic in London has tested drug levels in users of generic PrEP medication bought online and found the drugs are genuine and effective.

Tests found adequate levels of both emtricitabine and tenofovir (used in PrEP medication Truvada) in patients’ blood, and no sample suggesting counterfeit drugs.

Read more here
See conference program here

Read on Read later

London sexual health clinics step up their support for people buying PrEP online

By J Pope

In HIV

1 Min Read

L

nam/aidsmap, 29 January 2016 Several large sexual health clinics in London and Brighton have responded to the growing numbers of people importing PrEP medications from overseas by offering free safety monitoring to PrEP users. This is in a context of increasing frustration with the slowness of the official NHS process to approve PrEP – no decision will be made until June at the earliest. Read...

Read on Read later

Ipergay PrEP study results published

By J Pope

In HIV

1 Min Read

I

NAM , 02 December 2015 The results from the Ipergay study of intermittent pre-exposure prophylaxis (PrEP) were published in the New England Journal of Medicine (NEJM) on 1 December, World AIDS Day. The journal-published results are little changed from those presented at the CROI conference last February by principal investigator Jean-Michel Molina, but the researchers make a number of additional...

Read on Read later

PrEP Is Safe for People With Hepatitis B

By J Pope

In Hepatitis, HIV

1 Min Read

P

AIDSMEDS, August 17, 2015
People with hepatitis B virus (HBV) can safely take Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP), as it does not lead to liver inflammation “flares” or other health problems when it is used or discontinued.
Read more here

Read on Read later

Tagemtricitabine